SI

Sofinnova Investments Portfolio holdings

AUM $1.47B
1-Year Est. Return 17.43%
This Quarter Est. Return
1 Year Est. Return
+17.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.33B
AUM Growth
-$38.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1
+$68M
2
+$50.6M
3
+$31.7M
4
PTCT icon
PTC Therapeutics
PTCT
+$29.5M
5
IDYA icon
IDEAYA Biosciences
IDYA
+$25.4M

Top Sells

1
+$63.9M
2
+$42.7M
3
+$39.8M
4
AXSM icon
Axsome Therapeutics
AXSM
+$36.9M
5
BSX icon
Boston Scientific
BSX
+$31M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAPP
26
Rapport Therapeutics
RAPP
$1.2B
$20M 1.31%
1,995,594
SUPN icon
27
Supernus Pharmaceuticals
SUPN
$2.96B
$17.1M 1.11%
+520,678
SVRA icon
28
Savara
SVRA
$754M
$15.2M 0.99%
5,481,666
+10,367
COGT icon
29
Cogent Biosciences
COGT
$2.11B
$13.1M 0.85%
2,182,121
+1,358,961
ROIV icon
30
Roivant Sciences
ROIV
$12.4B
$12.9M 0.84%
+1,279,510
DHR icon
31
Danaher
DHR
$158B
$12M 0.78%
58,606
+48,606
PEN icon
32
Penumbra
PEN
$9.87B
$11.5M 0.75%
+42,936
RNA icon
33
Avidity Biosciences
RNA
$7.17B
$11.2M 0.73%
379,931
+366,142
INBX icon
34
Inhibrx
INBX
$830M
$9.76M 0.64%
697,916
+170,726
YMAB
35
DELISTED
Y-mAbs Therapeutics
YMAB
$9.72M 0.63%
2,194,278
JBIO
36
Jade Biosciences
JBIO
$460M
$9.43M 0.62%
107,391
PHVS icon
37
Pharvaris
PHVS
$1.48B
$9.32M 0.61%
593,403
+32,680
BIOA
38
BioAge Labs
BIOA
$272M
$8.67M 0.57%
2,304,901
RCUS icon
39
Arcus Biosciences
RCUS
$1.84B
$8.15M 0.53%
+1,037,776
EWTX icon
40
Edgewise Therapeutics
EWTX
$1.6B
$7.53M 0.49%
342,218
-60,555
DYN icon
41
Dyne Therapeutics
DYN
$2.44B
$7.5M 0.49%
716,896
-354,602
IMTX icon
42
Immatics
IMTX
$1.24B
$7.01M 0.46%
1,554,304
+1,211,098
PRAX icon
43
Praxis Precision Medicines
PRAX
$4.33B
$5.97M 0.39%
+157,640
ISRG icon
44
Intuitive Surgical
ISRG
$194B
$5.94M 0.39%
11,984
-25,912
QURE icon
45
uniQure
QURE
$3.76B
$5.79M 0.38%
+545,771
IMNM icon
46
Immunome
IMNM
$1.37B
$5.31M 0.35%
788,666
+41,842
KURA icon
47
Kura Oncology
KURA
$842M
$5.23M 0.34%
+791,667
INZY
48
DELISTED
Inozyme Pharma
INZY
$3.9M 0.25%
4,280,308
SRRK icon
49
Scholar Rock
SRRK
$2.85B
$3.73M 0.24%
+116,117
ERAS icon
50
Erasca
ERAS
$675M
$2.57M 0.17%
1,877,085
+81,205
1
2
3 4